First Year Impact of Nirsevimab on Paediatric Respiratory Syncytial Virus Infection and Hospitalisations in the Australian Capital Territory

Clinical trial NCT07177508 · COMPLETED

Trial details

NCT number: NCT07177508
Sponsor: Nicola Irwin
Status: COMPLETED
Study type: OBSERVATIONAL

Respiratory Syncytial Viral (RSV) Infection Respiratory Syncytial Virus Hospitalizations Respiratory Syncytial Virus Prevention

Start date: 2024-12-01
Primary completion: 2025-07-30
Enrollment: 2355

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.